Received May 13, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (PRIORIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 342RC | — |
administered an expired dose of priorix; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 68-year-old male patient who received MMR (Priorix) (batch number 342RC, expiry date 01-MAY-2025) for prophylaxis. On 07-MAY-2025, the patient received Priorix. On 07-MAY-2025, an unknown time after receiving Priorix, the patient experienced expired vaccine used (Verbatim: administered an expired dose of priorix). The outcome of the expired vaccine used was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 08-MAY-2025 The Vaccine Administration Facility is the same as Primary Reporter. The Health Center Manager called to ask about guidance on revaccination for an adult male patient that was administered an expired dose of Priorix vaccine which led to expired vaccine used.